{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:02:06Z","timestamp":1773392526834,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.resinv.2023.12.015","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:55:38Z","timestamp":1704848138000},"page":"206-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7087-1595","authenticated-orcid":false,"given":"Yosuke","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Horita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Aga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0214-1571","authenticated-orcid":false,"given":"Fumihiro","family":"Kashizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Obase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-307X","authenticated-orcid":false,"given":"Takeshi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2023.12.015_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.alit.2019.06.003","article-title":"Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2023.12.015_bib2","first-page":"848","article-title":"Economic burden of illness among patients with severe asthma in a managed care setting","volume":"22","author":"Chastek","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.resinv.2023.12.015_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2023.12.015_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-2600(14)70107-9","article-title":"The role of macrolides in asthma: current evidence and future directions","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2023.12.015_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.chest.2022.02.025","article-title":"Azithromycin for poorly controlled asthma in children","volume":"161","author":"Ghimire","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2023.12.015_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ppul.25783","article-title":"The efficacy and safety of azithromycin in treatment for childhood asthma: a systematic review and meta-analysis","volume":"57","author":"Pan","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2023.12.015_bib7","article-title":"The efficacy and safety of long-term add-on treatment of azithromycin in asthma: a systematic review and meta-analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2023.12.015_bib8","article-title":"Macrolides versus placebo for chronic asthma","volume":"11","author":"Undela","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resinv.2023.12.015_bib9","year":"2023","journal-title":"GINA Main Report"},{"key":"10.1016\/j.resinv.2023.12.015_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.resinv.2023.12.015_bib11","unstructured":"Cochrane. Cochrane Handbook for Systematic Reviews of Interventions, https:\/\/training.cochrane.org\/handbook\/current [accessed 14 August 2023]."},{"key":"10.1016\/j.resinv.2023.12.015_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre andomized double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2023.12.015_bib13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1183\/09031936.00093913","article-title":"Randomised controlled trial of azithromycin in smokers with asthma","volume":"42","author":"Cameron","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.12.015_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a andomized, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2023.12.015_bib15","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1371\/journal.pctr.0010011","article-title":"Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma","volume":"1","author":"Hahn","year":"2006","journal-title":"PloS Clin Trials"},{"key":"10.1016\/j.resinv.2023.12.015_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3122\/jabfm.2012.04.110309","article-title":"Yale S, on behalf of the AZMATICS (AzithroMycin-Asthma trial in community settings) study group. Azithromycin for bronchial asthma in adults: an effectiveness trial","volume":"25","author":"Hahn","year":"2012","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.resinv.2023.12.015_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106494","article-title":"Effect of azithromycin on bronchial wall thickness in severe persistent asthma: a double-blind placebo-controlled randomized clinical trial","volume":"185","author":"Sadeghdoust","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2023.12.015_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2010.07.024","article-title":"A trial of clarithromycin for the treatment of suboptimally controlled asthma","volume":"126","author":"Sutherland","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2023.12.015_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.resinv.2022.12.007","article-title":"Real-world evaluation of asthma reliever therapy among continuous users of asthma maintenance medication in Japan: a retrospective cohort study using a claims database","volume":"61","author":"Hozawa","year":"2023","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2023.12.015_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anai.2012.08.014","article-title":"Short-acting \u03b2-agonist use and its ability to predict future asthma-related outcomes","volume":"109","author":"Stanford","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.resinv.2023.12.015_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/npjpcrm.2014.9","article-title":"Asthma control and management in 8,000 European patients: the recognise asthma and link to symptoms and experience (REALISE) survey","volume":"24","author":"Price","year":"2014","journal-title":"Npj Prim Care Respir Med"},{"key":"10.1016\/j.resinv.2023.12.015_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2147\/JAA.S292943","article-title":"High use of SABAs is associated with higher exacerbation rate in Dutch patients with asthma","volume":"14","author":"Baron","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.resinv.2023.12.015_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting \u03b2 2 -agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.12.015_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/thoraxjnl-2020-216331","article-title":"Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy","volume":"76","author":"Shukla","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2023.12.015_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.alit.2019.10.011","article-title":"Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency","volume":"69","author":"Tiotiu","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2023.12.015_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pupt.2015.12.002","article-title":"Long-term azithromycin ameliorates not only airway inflammation but also remodeling in a murine model of chronic asthma","volume":"36","author":"Kang","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resinv.2023.12.015_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AAC.02067-13","article-title":"Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2023.12.015_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2023.12.015_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0137-2019","article-title":"Minimal clinically important difference for asthma endpoints: an expert consensus report","volume":"29","author":"Bonini","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.resinv.2023.12.015_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European respiratory society\/American thoracic society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.12.015_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1399-3003.2000.15b06.x","article-title":"Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma","volume":"15","author":"Black","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2023.12.015_bib32","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaci.2015.09.032","article-title":"Incident asthma and Mycoplasma pneumoniae: a nationwide cohort study","volume":"137","author":"Yeh","year":"2016","journal-title":"J Allergy Clin Immunol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253452400008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253452400008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:33:11Z","timestamp":1761949991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221253452400008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S221253452400008X"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2023.12.015","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2023.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}